IVUPDATE from IVTEAM

IVTEAM is a global resource for vascular access and infusion therapy, dedicated to supporting clinical teams worldwide. Our daily updates help healthcare professionals stay current with the latest evidence in vascular access and infusion therapy.

Central venous access devices for neonates – Full Text

“Optimal CVAD selection is not merely a technical decision but a strategic clinical process that integrates patient, therapy, device, and health-system factors. Existing frameworks provide valuable guidance and should be interpreted within the clinical context in which they are applied, acknowledging differences in expertise, available resources, and models of care” de Souza et al (2026).

Read More »

Neuromuscular blocking drug extravasation – Full Text

“This case highlights the unpredictable clinical course of NMBD extravasation and demonstrates that recurrent paralysis may occur despite initial successful reversal, requiring quantitative neuromuscular monitoring, extended postoperative observation, and administration of repeat doses of sugammadex as delayed systemic absorption occurs” Crafton et al (2026).

Read More »

Continuous intravenous acyclovir during OPAT – Full Text

“The acyclovir OPAT programme led to cost savings of 3486 EUR per patient. Despite this small case series, continuous intravenous acyclovir appears to be feasible for treating HSV and VZV neurological infections in an OPAT setting, with potential benefits in patient comfort, healthcare costs, and hospital resource utilization” Manders et al (2026).

Read More »

Vascular complications of intravenous vancomycin

“To map and describe the available clinical evidence on the safety and vascular complications associated with peripheral intravenous administration of vancomycin, compared with other vascular access devices, focusing on the type of complications reported, their diagnostic methods, and the methodological characteristics of the studies” Fernández-Aedo et al (2026).

Read More »